Rethinking the management of immune checkpoint inhibitor‐related adrenal insufficiency in cancer patients during the COVID‐19 pandemic-Reference-Cited by-同舟云学术

Rethinking the management of immune checkpoint inhibitor‐related adrenal insufficiency in cancer patients during the COVID‐19 pandemic

Published:2021-03-08 Issue:3 Volume:4 Page:
ISSN:2398-9238
Container-title:Endocrinology, Diabetes & Metabolism
language:en
Short-container-title:Endocrinol Diab Metab

Author:

Yuen Kevin C. J.¹^ORCID,Mortensen Michael J.²,Azadi Amir³,Fonkem Ekokobe³,Findling James W.⁴

Affiliation:

1. Departments of Neuroendocrinology and Neurosurgery Barrow Neurological Institute University of Arizona College of Medicine and Creighton School of Medicine Phoenix Arizona USA

2. University of Arizona College of Medicine‐Phoenix Phoenix Arizona USA

3. Departments of Neurology and Neuro‐Oncology Barrow Neurological Institute/Ivy Brain Center at Phoenix St. Joseph’s Hospital and Medical Center Phoenix Arizona USA

4. Division of Endocrinology and Molecular Medicine Medical College of Wisconsin Milwaukee Wisconsin USA

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/edm2.246

Reference79 articles.

1. Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle

2. Patients with cancer appear more vulnerable to SARS‐CoV‐2: a multicenter study during the COVID‐19 outbreak;Dai M;Cancer Discov,2020

3. Do patients with cancer have a poorer prognosis of COVID-19? An experience in New York City

4. Determinants of COVID-19 disease severity in patients with cancer

5. Cancer immunotherapy using checkpoint blockade

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endocrine immune-related adverse events: Adrenal, parathyroid, diabetes insipidus, and lipoatrophy;Best Practice & Research Clinical Endocrinology & Metabolism;2022-05